MedTrace Logo

Iris Tissue in Primary Congenital Glaucoma

NCT04079725 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-10-22

No results posted yet for this study

Summary

To present the histopathological features of the iris tissue in primary congenital glaucoma which may play a role in pathogenesis

Conditions

  • Primary Congenital Glaucoma

Interventions

PROCEDURE

Combined trabeculotomy-trabeculectomy with mitomycin c

Combined trabeculotomy-trabeculectomy with mitomycin C Will be done in all cases then histopathological examination of iris tissue to detect the nature of the disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Days
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-09-30
Completion
2022-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04079725 on ClinicalTrials.gov